Development of a comprehensive gene mutation testing system named Mutation Investigator using the Next-era Sequencer (MINtS)

Development of a comprehensive gene mutation testing system named Mutation Investigator using the Next-era Sequencer (MINtS) - NEJ021A

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015665

Enrollment

3000

Registered

2014-11-11

Start date

2014-11-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Non small cell lung cancer patients on pathological examination 2 Pathological samples including cancer cells 3 Patients approved informed consent

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
Detecting rates of EGFR, ALK, KRAS, BRAF, RET, ROS1 gene mutations, BIM gene polymorphism, and others after adjusting pathology, age, sex, and smoking history	—

Countries

Japan

Contacts

Public ContactKunihiko Kobayashi

Saitama Medical University International Medical Center Department of Respiratory Medicine

kobakuni@saitama-med.ac.jp042-984-4667

Outcome results